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SUMMARY
GATA2 is essential for the endothelial-to-hematopoietic transition (EHT) and generation of hematopoietic stem cells (HSCs). It is poorly
understood how GATA2 controls the development of human pluripotent stem cell (hPSC)-derived HS-like cells. Here, using human
embryonic stem cells (hESCs) in which GATA2 overexpression was induced by doxycycline (Dox), we elucidated the dual functions of
GATA2 in definitive hematopoiesis before and after the emergence of CD34+CD45+CD90+CD38– HS-like cells. Specifically, GATA2 pro-
moted expansion of hemogenic precursors via the EHT and then helped to maintain HS-like cells in a quiescent state by regulating cell
cycle. RNA sequencing showed that hPSC-derivedHS-like cells were very similar to human fetal liver-derivedHSCs. Our findingswill help
to elucidate the mechanism that controls the early stages of human definitive hematopoiesis and may help to develop a strategy to
generate hPSC-derived HSCs.
INTRODUCTION
Primitive hematopoiesis initiates in the yolk sac with a tran-
sient wave of primitive erythroid progenitors; however,
definitive hematopoiesis occurs via a temporally and
spatially dynamic pattern (Palis et al., 1999). The definitive
hematopoiesis firstly generates erythroid with adult-type
features but does not produce hematopoietic stem cells
(HSCs) in the yolk sac (Bo¨iers et al., 2013). The second
wave of definitive hematopoiesis is marked by the emer-
gence of HSCs originated from hemogenic endothelium
(HE) in the aorto-gonad-mesonephros (AGM) region of
the embryo through the endothelial-to-hematopoietic tran-
sition (EHT) (Boisset et al., 2010; Ivanovs et al., 2011; Med-
vinsky and Dzierzak, 1996; Swiers et al., 2013; Taoudi et al.,
2008), while more pre-HSCs generated from AGM region
move to the fetal liver (FL) and then acquire a mature HSC
property (Rybtsov et al., 2016). Developmental hematopoi-
esis has been mainly studied in mouse models, but early
human hematopoiesis is poorly understood. The establish-
ment of human embryonic stem cells (hESCs) and human
induced pluripotent stem cells (hiPSCs) led to the develop-
ment of models that are ideal to explore early hematopoie-
sis in humans (Costa et al., 2012; Takahashi et al., 2007;
Thomson et al., 1998; Yoder, 2014). Several recent studies re-
ported the development of hPSC-derived early mesodermal
precursors intomature hematopoietic stem/progenitor cells
(HSPCs) in vitro (Ng et al., 2016; Slukvin, 2016). The latter
cells can be traced as CD34+CD43+CD45+CD90+CD38–
cells; these surface markers are typical of human HSCs
emerging in AGM and FL in vivo (Rowe et al., 2016).
Although phenotypically similar to their adult-type coun-
terparts in AGM, hPSC-derived HSPCs generated in vitro
cannot reconstitute hematopoiesis in NOG-SCID mice
(Ng et al., 2016). Gene manipulation has been performed
to enhance the HSC property of hPSC-derived HS-like
cells. Overexpression of medial HOXA genes prolongs
the maintenance of hESC-derived HSPCs but does not
confer self-renewal in hESC-derived HSPCs (Dou et al.,
2016). A more recent study showed that hESC-derived
CD34+KDR+CD43GPA– HE cells with a definitive hemato-
poietic potential reconstitute hematopoiesis in NOG-SCID
mice when transfected with five transcription factors
(HOXA9, ERG, RORA, SOX4, and MYB) (Sugimura et al.,
2017). However, this previous study did not purify HSCs
in vitro. It remains challenging to generate hPSC-derived
HSCs in vitro.
The transcription factorGATA2 plays a unique role in the
development, maintenance, and quiescence of HSCs,
particularly in the AGM. In mouse embryos, Gata2 is
expressed in lateral plate mesoderm (LPM)-, AGM-, and
FL-derived HSCs (Minegishi et al., 1999, 2003). Knockout
(KO/–) of Gata2 blocks the development of murine HSCs
in the AGM region. Deletion of a cis element located
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Figure 1. Generation and Analysis of G2/hESCs
(A) Schematic illustration of the PB Tet-on inducible expression system and the strategy used to establish G2/hESCs.
(B) Immunofluorescence staining of pluripotency markers in G2/hESCs. Scale bars, 50 mm.
(C) Confirmation of homologous recombination in G2/hESCs by PCR. Genomic DNA was isolated from wild-type hESCs, GFP-expressing
hESCs, and G2/hESCs.
(D) Fluorescence and phase-contrast images of G2/hESCs cultured in mTeSR1 medium containing and lacking Dox. Scale bars, 50 mm.
(E) Western blotting and qRT-PCR analysis of GATA2 expression in various concentrations of Dox (0–8 mg/mL)-treated G2/hESCs and AGM-
S3 cocultures (G2/hESC cocultures) on day 7.
(F) qRT-PCR analysis of GATA2 expression in various concentrations of Dox (0–8 mg/mL)-treated G2/hESCs and AGM-S3 cocultures
(G2/hESC cocultures) on day 7.
(legend continued on next page)
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9.5 kb downstreamof theGata2 promoter (+9.5) inmice de-
creases Gata2 expression in HE in AGM, and abrogates the
EHT (Gao et al., 2013). RNA sequencing (RNA-seq) demon-
strated that GATA2 and other HSC-specific genes are upre-
gulated in human CD34+CD45+CD38– (34+45+38–) HSPCs
derived from HE-5TF cells (Sugimura et al., 2017). GATA2-
knockout hESCs exhibit marked defects in the EHT and
conversion into HSPCs, while specification of HE is unaf-
fected (Kang et al., 2018). By contrast, GATA2/eGFP+ hESCs
give rise to an increased number of HSPCs (Huang et al.,
2016). During the development of hPSCs into HSPCs
in vitro, expression of GATA2 is upregulated along with
the KDR+APLNR+CD34CD43– early mesodermal precur-
sors (Choi et al., 2012). On the other hand, overexpression
of GATA2 (GATA2-OE) hampers, rather than enhances,
HSC activity in human cord blood (CB)-derived CD34+
HSCs by inducing cell-cycle arrest at the G0/G1 phase
(Tipping et al., 2009). Thus, GATA2 has diverse effects on
the early stages of mesodermal hematopoietic lineage spec-
ification, the EHT, and maintenance of HSCs. It is un-
known how GATA2 elicits these effects and at what level
GATA2 influences the cell fate decision.
We previously reported an efficient coculture system
with AGM-S3 cells that facilitates definitive hematopoie-
sis of hPSCs in vitro (Mao et al., 2016; Wang et al., 2018).
In the current study, we established hESCs in which
GATA2-OE was induced by treatment with doxycycline
(Dox) using a PiggyBac (PB)-based Tet-on system, and
the functional role of GATA2 in the early stages of hema-
topoiesis was analyzed. Our data revealed that GATA2
functions at different time points to initiate, enhance,
and maintain definitive hematopoiesis of hESCs by
regulating the cell cycle. Specifically, GATA2 exerts dual
functions by promoting the generation of definitive
hematopoietic progenitors before and after the EHT and
arresting CD34+CD45+CD90+CD38– (34+45+90+38–) HS-
like cells in a quiescent state.
RESULTS
Generation of an hESC Line with Inducible GATA2
Overexpression
To explore the function of GATA2 in hematopoietic fate
determination, we generated H1-GFP-GATA2 hESCs (G2/
hESCs) in which exogenous expression of GATA2 was
induced on treatmentwithDoxusing a previously described
PB-based Tet-on system (Figure 1A) (Chen et al., 2017). In
the absence of Dox, G2/hESCs expressed key stemness-
specific markers, such as SOX2, OCT4, and SSEA4 (Fig-
ure 1B). PCR analysis verified that the coding sequence
(CDS) of GATA2 was integrated into the genome of
G2/hESCs (Figure 1C). G2/hESCs could be repeatedly
passaged and retained a hESC phenotype without Dox (Fig-
ure 1D). Western blotting and qRT-PCR showed increased
expression of GATA2 in G2/hESCs and AGM-S3 cocultures
(G2/hESC cocultures) with increased concentration of Dox
from 0 to 4 mg/mL (Figures 1E and 1F). Treatment with
Dox (1mg/mL) increased the percentage of GFP+ cells and
the mRNA expression of GATA2 in G2/hESCs from 0 to
96 h (Figures 1D, 1G, and 1H). Therewere three hESC clones
used for the experimentswith 1, 2, and 4 copies of transgene
detected by qPCR, respectively (Figure 1I) (Christodoulou
et al., 2016); The three hESC clones showed increased
expression of GATA2 mRNA and protein with increased
copies of transgene detected by qRT-PCR and western blot-
ting (Figures 1I and 1J). These results demonstrated that
G2/hESCs were pluripotent and had a normal phenotype,
that the CDS of GATA2 was integrated into the genome of
these cells, and that treatment with Dox-induced GATA2-
OE from 0 to 4 mg/mL.
GATA2 Overexpression in hESCs Promotes Definitive
Hematopoiesis
We firstly elucidated the hematopoietic cells in the H1
hESCs and AGM-S3 cocultures (Figure 2A). KDR+ cells,
which are mesodermal precursors of hematopoietic and
endothelial lineages, gradually expressCD34duringhuman
embryonic development (Corte´s et al., 1999). In H1 hESCs
and AGM-S3 coculture, the KDR+CD34CD43– (K+34–43–)
cells mainly expressed mesodermal proteins and genes
compared with the KDR+CD34+CD43– (K+34+43–) cells (Fig-
ures S1A and S1B). CD43 was previously used as a marker of
hematopoietic progenitors in cocultures of hPSCs and OP9
cells (Vodyanik et al., 2006). CD34+CD43+ (34+43+) cells
expressed markers of hematopoietic progenitors and upre-
gulated hematopoietic genes compared with CD34+CD43–
(34+43–) cells (Figures S1C and S1D). In cocultures of H1
hESCs and AGM-S3 cells, the former cells differentiate
into (APLNR+KDR/+CD34–, A+K/+34–) mesodermal pro-
genitors (CD34+CD43–, 34+43–) endothelial cells, and
(CD34+CD43+CD45/+, 34+43+45/+) hematopoietic pro-
genitors in a stepwise manner (Figures S1E and S1F), as
occurs in other hematopoietic systems (Slukvin, 2013).
(G) Flow cytometric analysis of the percentage of GFP+ cells among Dox-treated G2/hESCs.
(H) qRT-PCR analysis of GATA2 expression in G2/hESCs treated with Dox for 0–96 h.
(I and J) Western blotting (I) and qRT-PCR (J) analysis of GATA2 expression in G2/hESC cocultures on day7 derived from three different
G2/hESC clones with various transgene copy number.
Error bars represent mean ± SD of samples from at least three independent experiments. NS, not significant; *p < 0.05, **p < 0.01.
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GATA2 expression was upregulated during hematopoiesis
(Figure S1G). GATA2 expression in 34+43+ and 34+45+ he-
matopoietic cells derived from H1 hESCs was comparable
with that in human CB-derived CD34+ cells (Figure S1H).
These data demonstrate that the AGM-S3 stromal cell line
efficiently induced hematopoietic differentiation of hESCs
and simulated the early stages of hematopoiesis (Figure S1I)
(Mao et al., 2016; Wang et al., 2018). Expression of GATA2
increased during the development of 34+43+45/+ hemato-
poietic cells from hESCs.
We further evaluated the role of GATA2 in hematopoiesis
by three different culture systems. The hematopoietic effi-
ciency in the promotion of 34+45+90+38– cells was
improved in AGM-S3 coculture than in OP9 and stromal
cell-free culture (Figure S1J). Transition of 34+K+43– cells
into 34+43+ cells was predominantly enhanced in AGM-
S3 cocultures (Figure S1K). A comparable increase of
GATA2 expression was paralleled to the increase of Dox
dose from 0 to 4 mg/mL, accompanying by an enhanced
promotion of 34+43+ cells in G2/hESC cocultures (Fig-
ure S2A). We found 1 mg/mL Dox was enough to trigger
GATA2 overexpression, and this dose was used in further
experiments. We found that all three hESC lines with
different transgene copy numbers demonstrated similar
efficacy in promoting hematopoiesis; however, there was
a slight difference in enhancement (Figures S2B and S2C).
On the other hand, the vector control hESCs showed
no difference in differentiation with and without Dox
(Figure S2C). To identify barriers to the generation of he-
matopoietic cells from GATA2-overexpressing hESCs, we
analyzed the proportion of hematopoietic cells among
G2/hESC cocultures at days 6, 10, and 14, when Dox treat-
ment was initiated at different time points (Figure S2D).
Addition of Dox from day 2 until the day of collection pro-
moted the development of K+34–43–, 34+K+43–, 34+43+,
and 34+43+45+ cells (Figure S2D).
We next evaluated the effect GATA2-OE on hematopoie-
sis from day 2 to 22. The increased level of GATA2 expres-
sion mainly relied on exogenous GATA2 expression both
at the various times of differentiation and in the 34+43+-
sorted cells with Dox (Figures S2E and S2F). The total cell
number was not markedly affected (data not shown).
GATA2-OE prolonged the growth of 34+43+45/+ and
34+45+90+38– cells in cocultures over 22 days (Figures 2B
and S2G). Moreover, GATA2-OE increased the generation
of 34+45+90+38– HS-like cells by more than 4.8-fold in co-
cultures. Total cells collected from Dox-treated cocultures
on days 14, 20, and 22 formed an increased number of col-
onies, which coincided with the increase in hematopoietic
cells; however, more colonies were observedwhenDoxwas
removed during the colony-formation assay (Figure 2C).
BFU-E andMix colonies recovered when Dox was removed
in cloned cultures (Figure 2D).
Fluorescence-activated cell sorting (FACS) analysis
demonstrated that the levels of 34+43+45– cells (pre-HSPCs),
34+43+45+ cells (HSPCs), and 34+45+90+38– cells (HS-like
cells) were increased in Dox-treated cocultures at day 14
(Figures 2E and 2F). Immunofluorescence staining of
CD34 and CD43 showed that dense networks of blood
vessels and many hematopoietic cells formed in Dox-
treated cocultures on day 14 (Figure 2G).These data demon-
strate that GATA2-OE promotes the generation of hemato-
poietic cells and prolongs the colony-forming unit (CFU)
potential of cocultured cells.
GATA2 Overexpression Promotes Definitive
Hematopoiesis via Differentiation of hESC-Derived
Mesodermal KDR+CD34– (K+34–) Cells and the EHT
The percentage and number of early mesodermal cells with
an A+K–34– phenotype did not markedly differ. However,
the number of K+34– cells, including definitivemesodermal
cells with an A+K+34– phenotype, was higher in Dox-
treated cocultures than in untreated cocultures (Figures
3A and S3A). Expression of primitive streak (PS) and LPM
genes increased on Dox treatment (Figure 3B). Thus,
GATA2-OE promoted the generation of hESC-derived
mesodermal K+34– cells, including A+K+34– and AK+34–
cells.
The increase in 34+43+ cells in cocultures on GATA2-OE
may be because of the promotion of EHT and after EHT.
To determine whether GATA2-OE promotes EHT, 34+K+43–
cells were sorted from cocultures on day 6 and recultured
on AGM-S3 cells in the presence or absence of Dox (Figures
3C and 3D). 34+K+43– cells gave rise to more 34+43+ cells,
Figure 2. GATA2-OE in hESCs Promotes Definitive Hematopoiesis
(A) Experimental scheme to study the stage-wise effect of GATA2 on hematopoietic development.
(B) Absolute numbers of 34+43+, 34+43+45+, and 34+45+90+38 cells in untreated and Dox-treated G2/hESC cocultures on days 2–22.
(C) Colony formation by total cells collected from untreated and Dox-treated G2/hESC cocultures on days 14, 20, and 22.
(D) Formation of BFU-E and Mix colonies by total cells collected from untreated and Dox-treated G2/hESC cocultures on day 14.
(E) Percentages and absolute numbers of 34+43+45–, 34+43+45+, and 34+45+90+38– cells in untreated and Dox-treated G2/hESC cocultures
on day 14.
(F) Flow cytometric analysis of 34+43+45+ cells in untreated and Dox-treated G2/hESC cocultures on day 14.
(G) Immunofluorescence staining of CD34 and CD43 in untreated and Dox-treated G2/hESC cocultures on day 14. Scale bars, 100 mm.
Error bars represent mean ± SD of samples from at least three independent experiments. NS, not significant; *p < 0.05, **p < 0.01.
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including 34+43+K+/– and 34+43+45/+ cells, in the presence
of Dox (Figures 3E and S3B). Immunofluorescence staining
revealed that 34+K+43– cells gave rise tomoreCD43+ cells on
GATA2-OE for 7 days (Figure 3F). To investigate the effect of
GATA2-OE on expansion of 34+43+45– and 34+43+45+ cells
after the EHT, both cell populations were sorted from
cocultures on day 14 and recultured on AGM-S3 cells (Fig-
ure 3C). GATA2-OE did not markedly affect the expansion
of 34+43+45+ cells (Figure 3G).
To further elucidate the effect of GATA2-OE on EHT,
cocultures on day 4, which lacked emerging CD43+ cells,
were transfected with GATA2-targeting (si-GATA2: GUCC
AAGAAGAGCAAGAAATT) or control siRNA (si-N:UUCU
CCGAACGUGUCACGUTT) (Figure S3C). Transfection of
20 nM si-GATA2 significantly decreased endogenous
GATA2 expression bymore than 42.3% (Figure 3H). Down-
regulation of GATA2 decreased the emergence of 34+43+
cells (Figures 3I and S3C).
Relative gene expression profiles differed between
34+K+43– cells sorted from untreated and Dox-treated co-
cultures on day 6. Hematopoietic genes were upregulated
in 34+K+43– cells on GATA2-OE (Figure 3J).
These data suggest that GATA2-OE promotes the genera-
tion of 34+43+ cells through the EHT in cocultures of hESCs
and AGM-S3 cells, and that GATA2 is essential for the EHT
during hematopoiesis.
GATA2 Overexpression Inhibits the Differentiation of
34+45+ HSPCs
GATA2-OE increased production of CD34highCD45+
(34high45+) cells and inhibited production of 34low45+
and 34–45+ cells until day 16 of coculture (Figures 4A and
S4A). Flow cytometric analysis demonstrated that the per-
centages of cells positive for CD144, CD201, KDR, CD90,
and CD105were higher among 34high45+ cells than among
34low45+ and 34–45+ cells, whereas the percentages of cells
positive for lineage-specific markers such as CD38, CD13,
CD16, and CD14 were lower (Figures 4B and 4C). GATA2-
OE increased production of 34high45+ cells and inhibited
their differentiation into 34low45+ and 34–45+ cells (Figures
4A, 4B, and S4A). GATA2-OE did not obviously change
the immunophenotype of 34high45+ cells (Figure 4D).
When Dox was removed from day 10, differentiation of
34low45+ and 34–45+ cells was restored on day 14 (Fig-
ure 4E). Thus, GATA2-OE promoted the generation of
34high45+ cells and inhibited their differentiation.
To further elucidate the effect of GATA2-OE on differenti-
ation of 34+45+ cells, these cells were sorted from cocultures
onday14 (Figure4F).WesternblottingandqRT-PCRanalysis
demonstrated that GATA2 expression was upregulated in
34+45+ cells sorted from Dox-treated cocultures (Figure 4G).
Removal of Dox increased the numbers of BFU-E, Mix, GM,
andMcolonies, whileGATA2-OE increased thenumber ofG
colonies (Figures 4H and 4I). More CD71+GPA+ erythroid
cells were detected by FACS analysiswhenDoxwas removed
during the colony-formation assay (Figure S4B). BFU-E
formed from GATA2-overexpressing cocultured cells gener-
ated erythroid cells that predominantly expressed adult
b-globin (Figure 4J). These data demonstrate that GATA2-
OE inhibits the differentiation of hematopoietic cells.
To further investigate the effect of GATA2-OE on the
differentiation of 34+45+ cells, we recultured 34+45+ cells
on day 14 in IMDM containing 10% fetal bovine serum
(FBS) and seven cytokines. More cells with a 34–45+ pheno-
typewere produced in the presence of Dox (Figures S4C and
S4D).Uponsuspensionof cultures to inducedifferentiation,
Dox treatment decreased the percentage of CD163+CD14+
cells (macrophages), but increased the percentages of
Figure 3. GATA2-OE Promotes Development of 34+43+45+ HSPCs via Mesodermal Differentiation and the EHT
(A) Absolute numbers of A+K–34–, A+K+34– , and AK+34– cells in untreated and Dox-treated G2/hESC cocultures on days 0–10.
(B) Heatmap of expression of genes associated with the development of germ layers in untreated and Dox-treated G2/hESC cocultures on
day 4. PL, pluripotency genes; PS, primitive streak genes; LPM, lateral plate mesoderm genes; PXM, paraxial mesoderm genes; IM,
intermediate mesoderm genes; EN, endodermal genes; EC, ectodermal genes.
(C) Experimental scheme. 34+K+43 cells and 34+43+45–/+cells were isolated from coculture at days 6 and 14, respectively, then recultured
for an additional 14 days onto AGM-S3-coated plates with and without Dox.
(D) Flow cytometric analysis of K+34+43– cells sorted from G2/hESC cocultures on day 6.
(E) The K+34+43– cells sorted from G2/hESC cocultures on day 6 were recultured on AGM-S3 cells with and without Dox. The numbers of
K+/–34+43+ and 34+43+45/+ cells were determined by flow cytometry.
(F) Microscopic analysis and immunofluorescence staining of CD43 in K+34+43– cells cocultured with AGM-S3 cells with and without Dox for
7 days. Scale bars, 50 mm.
(G) 34+43+45– and 34+43+45+ cells were sorted from G2/hESC cocultures on day 14 and recultured on AGM-S3 cells for 14 days with and
without Dox. The numbers of 34+43+45+ cells were determined by flow cytometry.
(H) qRT-PCR analysis of relative GATA2 expression in siRNA-transfected cells from day 4 G2/hESC cocultures.
(I) The absolute number of 34+43+ cells in cocultures treated with si-GATA2 (20 nM) or control siRNA for 2 and 4 days.
(J) Heatmap of gene expression in 34+K+43– cells derived from untreated and Dox-treated G2/hESC cocultures on day 6. M, mesodermal
genes; EG, endothelial genes; Hem, hematopoietic genes.
Error bars represent mean ± SD of samples from at least three independent experiments. NS, not significant; *p < 0.05, **p < 0.01.
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Figure 4. GATA2-OE Inhibits the Differentiation of CD34+CD45+ HSPCs
(A) Absolute numbers of 34high45+, 34low45+, and 34–45+ cells in untreated and Dox-treated G2/hESC cocultures on days 2–16.
(B) Flow cytometric analysis of 34+45+ cells in untreated and Dox-treated G2/hESCs co-cultures on day 14.
(C) Flow cytometric analysis of the subphenotype of 34high45+, 34low45+, and 3445+ cells in Dox-untreated G2/hESC cocultures on day 14.
(D) Flow cytometric analysis of the subphenotype of 34high45+ cells in untreated and Dox-treated G2/hESC cocultures on day 14.
(E) The percentage of 34high45+, 34low45+, and 34–45+ cells in untreated and Dox-treated G2/hESC cocultures on day 14.
(F–J) Properties of 34+45+ cells sorted from G2/hESC cocultures on day 14. (F) Flow cytometric analysis of 34+45+ cells sorted from
untreated and Dox-treated cocultures on day 14. (G) Western blotting and RT-qPCR analysis of GATA2 in 34+45+ cells sorted from untreated
and Dox-treated cocultures on day 14. (H–I) Colony formation by 34+45+ cells sorted from untreated and Dox-treated cocultures on day 14.
(J) b-Globin expression in BFU-E colonies derived from 34+45+ cells with and without Dox. Scale bars, 20 mm.
Error bars represent mean ± SD of samples from at least three independent experiments. NS, not significant; *p < 0.05, **p < 0.01.
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c-KIT+CD45+ (mast cells) and Siglec-8+CD88+ cells (eosino-
phils) (Figures S4C–S4E).
Thus, GATA2-OE increases production of 34+43+45+
cells, but prevents their differentiation in cocultures and
the colony-formation assay. By contrast, GATA2-OE in-
creases the granulocytic and mast cell potential of 34+45+
cells in suspension culture and the colony-formation assay.
GATA2 Overexpression Maintains HSPCs by Inducing
Cell-Cycle Arrest
50-Bromo-20-deoxyuridine (BrdU) incorporation analysis
suggestd that 34+45– cells differentiated into 34high45+
cells, which was accompanied by a decreased percentage
of cells in G0/G1 phase and an increased percentage of cells
in S stage (Figure 5A). The cell cycle of 34+45– cells did not
obviously differ between untreated and Dox-treated cocul-
tures at day 14 (Figure 5A). However, the cell cycle of 34+45+
cells differed between untreated andDox-treated samples at
day 14 of coculture and day 3 of suspension culture (Figures
5A–5D). The decreased generation of hematopoietic cells
from 34+45+ cells on Dox treatment was due to induction
of quiescence, while removal of Dox promoted progression
of 34+45+ cells into S and G2/M phase (Figures 5B and 5D).
Despite confirming GATA2-OE in 34+K+43– and 34+45+
cells treated with Dox, qRT-PCR analysis demonstrated
that the expression of cell-cycle-related geneswasmarkedly
altered in the latter cells (Figures 5E–5G). Expression of
genes encoding cell-cycle activators, such as CCND3,
MCM5, and CEBPA, was decreased in GATA2-OE 34+45+
cells. In addition, AHRR and CYB1P1 expression were
reduced in GATA2-OE 34+45+ cells (Figures 5F and 5G).
On removal of Dox from suspension cultures, expression
of GATA2 decreased in 34+45+ cells, while that of CD38
and CYB1P1 increased (Figure 5G). Enforced GATA-2
expression showed no increase in apoptosis of coculture
cells. GATA2-OE inhibited apoptosis in CD34highCD45+
cells on coculture day14 (Figure 5H). These data suggest
that GATA2-OE prevents the expansion and differentiation
of 34+45+ cells isolated from cocultures on day 14 by
inducing quiescence and inhibiting apoptosis.
GATA2 Overexpression Selectively Promotes the
Maintenance of 34+45+90+38– HS-like Cells
CD90+ cells were enriched among 34high45+ cells (Fig-
ure 4C). The percentages of cells positive for endothelial
markers, such as CD201, KDR, CD144, and CD61, were
higher among 34+45+90+38– HS-like cells than among
34+45+90–38– cells (Figure 6A). A two-step differentiation
protocol was applied to develop HS-like cells from H1
hESC cocultures on day14 (Figure 6B). Medium was re-
placed by a-minimum essential medium containing
20% FBS, thrombopoietin, stem cell factor, and FMS-like
tyrosine kinase 3 ligand (FL), which supports the mainte-
nance of multipotent human HS-like cells (Figure 6B). To
investigate the functional properties of GATA2-OE HS-like
cells, 34+45+90+38– HS-like cells were sorted and replated
onto AGM-S3 cells (Figure 6C). Although 34+45+90+38–
cells were detected in the presence of Dox, the percentage
of these cells rapidly decreased when Dox was removed
(Figures 6D, 6E, and S5A). To further elucidate the effect
of GATA2-OE on differentiation of hematopoietic cells,
cocultured cells on day 14 were cultured in differentiation
medium and their ability to differentiate into CD34+
CD45+CD38+ (34+45+38+) progenitors was investigated
(Figures 6F and S5B). The percentage of 34+45+38+ cells
by FACS and relative expression of CD38 in 34+45+ cells
by qRT-PCR increased when Dox was removed (Figures
5G, 6F, and S5B).
GATA2-OE promoted the development and mainte-
nance of 34+45+90+38– HS-like cells and inhibited their dif-
ferentiation into 34+45+38+ hematopoietic cells. These data
show that GATA2 selectively promotes the development
and maintenance of HS-like cells when expressed in the
correct cellular context.
GATA2 Overexpression Maintains 34+45+90+38– HS-
like Cells by Regulating Expression of Cell-Cycle-
Related Genes
To dissect the transcriptional features of 34+45+90+38– HS-
like cells, we isolated 34+45+90+38– and 34+45+38+ cells
from Dox-treated and -untreated G2/hESC cocultures and
performed RNA-seq. Thereafter, we compared the tran-
scriptional profiles of these cells with those of HSCs
(CD34+CD38CD90+CD45RA) and progenitors (CD34+
CD38+) derived from FL, CB, and bone marrow (BM) (Ce-
sana et al., 2018).
Unsupervised hierarchical clustering of GATA2-OE 34 +
45+90 + 38 cells (G2-OE 90+), 34 + 45+90 + 38 cells (90+)
and CD34+CD45+CD38+ cells (38+) showed that G2-OE
90+ and 90+ were positioned next to each other (Figure 7A).
Figure 5. GATA2-OE Promotes the Maintenance and Inhibits the Differentiation of HSPCs by Inducing Cell-Cycle Arrest
(A–D) Flow cytometric analysis and quantification of BrdU incorporation and 7-AAD staining to determine the cell-cycle distribution of
(A and C) 34+45+ HSPCs on day 14 of coculture and (B and D) day 3 of suspension culture.
(E–G) Gene expression profile of 34+K+43– cells (E) on day 6 of coculture, and (F) 34+45+ cells on 14 of coculture and (G) day 3 of suspension
culture.
(H) Apoptosis detection of hematopoietic cells from G2/hESC cocultures on day14 with and without Dox through flow cytometric analysis.
Error bars represent mean ± SD of samples from at least three independent experiments. NS, not significant; *p < 0.05, **p < 0.01.
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Gene expression patterns of hematopoietic markers,
cell surface markers and HSC regulators were very similar
in 34 + 45+90 + 38 cells, 34 + 45+38+ cells and that cells
derived from FL, CB, and BM (Figures 7B and S6A). Expres-
sion of mesodermal and endothelial genes was similar in
90+ cells and FL-derived HSCs (Figure 7B). Taken together,
the profiling data suggest that 90+ cells generated in vitro
are transcriptionally very similar to HSCs and are most
similar to human FL-derived HSCs.
HSC-specific gene expression was similar in untreated
and Dox-treated hESC-derived HS-like cells, suggesting
that GATA2-OE did not affect the HSC properties of these
A B
C D
E F
Figure 6. GATA2-OE Selectively Promotes the Maintenance of 34+45+90+38– HS-like Cells
(A) Flow cytometric analysis of the subphenotype of 34+45+90+38– and 34+45+90–38– cells from Dox untreated G2/hESC cocultures on
day 14.
(B) Analysis of the maintenance of HS-like 34+45+90+38– cells derived from H1 hESC cocultures on day 14. The absolute number of
34+45+90+38– cells on day 14 + 7 is shown.
(C) Flow cytometric analysis of 34+45+90+38– HS-like cells sorted from untreated and Dox-treated G2/hESC cocultures on day 14.
(D and E) Percentages and absolute numbers of (D) 34+45+90+38– and (E) 34+45+90–38– cells derived from sorted 34+45+90+38– cells
treated with and without Dox for 14 days.
(F) Expansion of 34+45+38+ cells derived from untreated and Dox-treated G2/hESC cocultures on day 14 in medium containing FBS and
cytokines.
Error bars represent mean ± SD of samples from at least three independent experiments. NS, not significant; *p < 0.05, **p < 0.01.
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cells (Figure 7B). We next assessed how GATA2-OE affects
the proliferation and differentiation of 90+ cells. In total,
5,058 genes (3,744 downregulated and 1,314 upregulated)
were significantly differentially expressed between G2-OE
90+ and 90+ cells (2.85-fold; Figures 7C and 7D). Repressed
genes in G2-OE 90+ cells were mostly enriched in gene
ontology categories related to cell adhesion, motility,
migration, proliferation, and differentiation (Figure 7E).
Kyoto Encyclopedia of Genes and Genome (KEGG) anal-
ysis suggestd that several pathways important for regula-
tion of HSCs were downregulated in G2-OE 90+ cells (Fig-
ure 7F). Gene set enrichment analysis (GSEA) showed
that the stem cell proliferation and differentiation genes
were repressed in G2-OE 90+ cells (Figures 7G and S6B).
GSEA showed that the positive regulation of mitotic cell-
cycle and apoptosis genes were repressed inG2-OE 90+ cells
(Figures 7H and S6C). Expression of genes related to the
AHR signaling pathway, which was previously reported to
be inhibited by SR1 (Rentas et al., 2016), was also inhibited
in G2-OE 90+ cells (Figure S6D).
DISCUSSION
The mechanism that controls the development and matu-
ration of hPSC-derived HSCs during definitive hematopoi-
esis remains to be elucidated, and its characterization is
hindered by the lack of a serial observation method.
GATA2 is expressed in a spatial- and temporal-dependent
manner during definitive hematopoiesis and is thus a
good marker to monitor early hematopoiesis of hPSCs. Us-
ing a PB-based Tet-on system to monitor GATA2-OE at
different stages of hematopoiesis, we found that GATA2
plays dual roles before and after the emergence of
34+43+45+ HSPCs during definitive hematopoiesis.
Lugus et al. (2007) reported that GATA2-OE promotes the
generation of mesodermal cells from mouse embryonic
stem cells. Forced expression of GATA2 stimulates hemato-
poietic specification at the mesodermal stage in a cell-
autonomous manner in Xenopus (Maeno et al., 1996).
However, knockout of GATA2 in hESCs does not markedly
affect specification ofmesodermal and endothelial lineages
before hematopoiesis (Kang et al., 2018).
In our coculture system, GATA2-OE enhanced the gener-
ation of K+34 cells, which further developed into K+34+
hemogenic cells, suggesting GATA2 may promote early
mesoderm differentiation toward endothelium and hema-
topoiesis. The discrepancy in the effects of GATA2
knockout and our overexpression system in mesodermal
development might be because of the differentiation con-
ditions used, the transient nature of K+34 mesodermal
cells, and the level of GATA2. A culture system favoring
mesoderm differentiation will be more suitable for clari-
fying it.
Analysis of definitive hematopoiesis in the AGM region
in conditional GATA2-knockout mice demonstrated that
GATA2 is essential for the EHT (de Pater et al., 2013; Gao
et al., 2013). The EHT is markedly inhibited in GATA2/
hESCs, and this effect is rescued by GATA2 overexpres-
sion (Kang et al., 2018). Consistently, in our coculture
system, GATA2-OE-induced expansion of K+34+43+ cells
followed by K–34+43+ cells. Definitive hematopoiesis-
related genes, including GATA1, RUNX1c, and SPI1,
were also upregulated in GATA2-OE 34+K+43– cells.
RUNX1c marked a subset of cells expressing CD34, a
cell surface marker present on human AGM-derived
HSCs (Ivanovs et al., 2014). RUNX1c tracked EHT in the
hematopoiesis of hESCs, while transcription factor
GATA2, GATA1, and SPI1 abundantly expressed in
RUNX1c+ cells compared with RUNX1c cells (Ng et al.,
2016). Thus, our data suggest that GATA2-OE enhances
definitive hematopoiesis through the promotion of EHT
with a conserved cooperation of these critical genes for
definitive hematopoiesis.
Figure 7. GATA2-OE Maintains 34+45+90+38– HS-like Cells by Regulating Expression of Cell-Cycle-Related Genes
(A) Unsupervised hierarchical clustering of RNA-seq data of 34+45+38+ (38+), 34+45+90+38– (90+) and G2-OE 34 + 45+90 + 38 (G2-OE 90+)
cells. RNA-seq of 38+, 90+, and G2-OE 90+ cells was performed on day 14 of G2/hESC cocultures. Data are from three representative
experiments (GEO: GSE122207).
(B) Heatmaps showing mesodermal, endothelial, HSC, and hematopoietic progenitor cell (HPC) genes that were differentially expressed in
G2-OE 90+, 90+, and 38+ cells. The scale is log2 RPKM (reads per kilobase of transcript per million). The data are from three FACS exper-
iments. The heatmaps showed significant differences in gene expression in 90+ and 38+ cells, p < 0.05. Expression of sample genes
previously reported to be regulators of mesodermal cells, endothelial cells, HSCs, and HPCs is shown. Expression profiles were investigated
in HSCs and progenitor cells derived from FL, CB, and BM (Cesana et al., 2018).
(C) Numbers of differentially expressed genes in G2-OE 90+ cells (fold change >2, p < 0.05).
(D) qRT-PCR analysis of GATA2 expression in 90+ cells and G2-OE 90+ cells.
(E and F) (E) Gene ontology categories of biological processes and (F) KEGG signaling pathways that were significantly downregulated in
G2-OE 90+ cells.
(G and H) Gene set enrichment analysis of (G) the stem cell proliferation and differentiation and (H) positive regulation of mitotic cell-
cycle genes were repressed in G2-OE 90+ cells.
Error bars represent mean ± SD of samples from at least three independent experiments. NS, not significant; *p < 0.05, **p < 0.01.
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The CD34medCD45+ fraction showed higherhemato-
poietic potential compared with CD34lowCD45+ and
CD34CD45+ cells from hESCs (Ditadi et al., 2015). In our
coculture system, the 34high45+ cell subset expressed a
low percentage of differentiation makers and resided more
in G0/G1 stage than CD34lowCD45+ and CD34CD45+
cell subsets, reflecting the hematopoietic potential was
enhanced in 34high45+ cell subset. Since maintenance of
dormancy and recovery on stimulation are themost impor-
tant characteristics for sustainingHSCs throughout life (Na-
kamura-Ishizu et al., 2014), the quiescence of 34high45+
GATA2-OE HSPCs and recovery in full hematopoietic activ-
ity when released from Dox showed their HS-like proper-
ties. The results are consistent with the previous finding
that GATA2 alters hematopoietic lineage specification and
cell differentiation (Hirasawa et al., 2002; Huang et al.,
2016; Tsai et al., 1994). Besides, GATA2-OE promotes quies-
cence in human CB-HSCs, sacrificing their proliferation
and performance in long-term culture-initiating cell assays
(Tipping et al., 2009). Enforced expression of GATA2 also
blocks proliferation and differentiation of murine BM cells
(Persons et al., 1999). GATA2 seems to elicit a critical
dose-dependent effect on maintenance of HSCs during
early and late hematopoiesis. A recent study demonstrated
that pulsatile changes inGATA2 expression subtly regulated
the generation of HSCs (Eich et al., 2017). Themechanisms
bywhichGATA2 regulates the generation andmaintenance
of HSCs at different developmental stages must be further
elucidated.
LinCD34+CD43+CD45+/CD90+CD38– cells in cocul-
tures of hESCs and OP9 cells were previously defined as
multipotent definitive hematopoietic progenitors (Slukvin,
2013). Recent studies showed that hESC-derived hemato-
poietic cells are very similar to human AGM- and FL-
derived HSCs in terms of their gene profiles and immuno-
phenotypes, and thus these cells are defined as HS-like cells
(Dou et al., 2016; Ng et al., 2016). In the current study,
GATA2-OE selectively maintained 34+45+90+38– HS-like
cells in cocultures for 2 weeks and inhibited their differen-
tiation into 34+45+38+ progenitor cells. RNA-seq demon-
strated that the maintenance of hESC-derived HS-like cells
on GATA2-OE was due to downregulation of stem cell pro-
liferation, differentiation, cell-cycle, and apoptosis path-
ways. Phosphatidylinositol 3-kinase-Akt signaling, which
maintains the properties of HSCs, were downregulated on
GATA2-OE (Juntilla et al., 2010). AHR antagonists such as
SR1 promoted the expansion of human HSCs (Boitano
et al., 2010). The downregulation of genes related to the
AHR pathway in G2-OE 90+ cells suggests that GATA2
maintains HS-like cells by inhibiting AHR signaling.
AGM-derived stromal cells were reported to predomi-
nantly support definitive hematopoiesis of hESCs (Ledran
et al., 2008). AGM-S3 cells induce maturation of immature
embryonic yolk sac cells and para-aortic splanchnopleure
cells into reconstituting HSCs (Matsuoka et al., 2001). In
the present study, AGM-S3 cells provided an ideal microen-
vironment for maintenance of 34+45+90+38– HS-like cells.
However, we failed to detect long-term engraftment of
these cells in immunodeficientmice (data not shown), sug-
gesting that intrinsic maturity and exogenous factors are
further required for gaining transplantable ability in
hESC-derived HS-like cells.
We provide evidence that complex and subtle regulation
of GATA2 is important for the development, expansion,
and maintenance of hESC-derived HS-like cells. GATA2
plays two functionally distinct roles in the generation
and expansion of HSCs in the AGM region and the prolif-
eration of HSCs in adult BM in mice (Ling et al., 2004). In
our system, the dual effects GATA2-OE on promoting early
hemogenic endothelial precursors (typically 34+43+45–
cells) through the EHT and later arresting 34+45+ cells in
a quiescent stage by cell-cycle regulation provided new
insight into its function in the maturation of hPSC defini-
tive hematopoiesis. Although we lack evidence of the
reconstitution potential of HS-like cells derived from cocul-
tures, the similar gene expression profiles for GATA2-OE
HS-like cells and human FL-derived HSCs suggest the possi-
bility to achieve functional HSCs by manipulating GATA2
expression. Our findings should help to elucidate the
mechanism controlling definitive hematopoiesis in hu-
mans by GATA2 regulation andmay assist in future clinical
applications.
EXPERIMENTAL PROCEDURES
Maintenance of hESCs
H1 hESCs were provided by Professor Tao Cheng and maintained
on Matrigel-coated plates in mTeSR1 medium (STEMCELL Tech-
nologies). The cells were dissociated into clumps using ReLeSR
(STEMCELL Technologies) every 4–5 days.
Establishment of G2/hESCs
H1 hESCs were seeded into a 24-well plate with 70%–90%
confluent at the time of transfection. Plasmid DNA-lipid com-
plexes (containing 0.5 mg of the PB-Tet-on-GFP-T2A-hGATA2
vector, and 0.5 mg of PB200PA vector containing catalytic compo-
nent) were added to the cells per well and incubated for 2–4 days
according to the manufacturer’s description of lipofectamine
3000 (Invitrogen). Transfected cells were selected by culture in
medium containing 1 mg/mL puromycin (Sigma). For single-cell
culture, cells were dissociated into single cells with Accutase
(Gibco) and maintained in mTeSR1 medium supplemented
with Y27632 (Cayman). Puromycin-resistant clones were picked,
and successful targeting was confirmed by western blotting, qRT-
PCR (F1:50-CAGCAAGGCTCGTTCCTGTTCA-30, R1:50-ATGAGT
GGTCGGTTCTGCCCAT-30) and PCR (F2: 50GAGGAAGTCTTC
TAACATGCGGT-30, R2: 50CCCTTCGTCTGACGTGGCAG-30). To
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minimize variation owing to long-term selection, multiple stable
cell lines were used and all experiments were repeated at least three
times. The study was approved by the Ethics Committee of the
Institute of Blood Transfusion, CAMS & PUMC.
Coculture of hESCs and AGM-S3 Cells
Approximately 50–60 clumps of hESCs, each of which contained
3–43 102 cells, were seeded onto 2–33105 irradiated AGM-S3 cells
in each well of a 6-well plate and cultured in hPSC maintenance
medium. hESCs were differentiated into HSPCs as described previ-
ously (Mao et al., 2016). The medium was changed every day.
Colony Assay
Hematopoietic potential of cells was assessed by culture on
methylcellulose (H4320, STEMCELL Technologies) supplemented
with 1% penicillin/streptomycin (Invitrogen) and cytokines,
which were described previously (Ma et al., 2008). BFU-E, CFU-
Mix, CFU-GM, CFU-G, and CFU-M colonies were assessed after
10–16 days.
Flow Cytometry and Cell Sorting
Cocultured cells were dissociated with 0.25% trypsin-EDTA solu-
tion (Invitrogen) and filtered through a 70-mm nylon mesh to
obtain a single-cell suspension. Flow cytometry was performed us-
ing a FACSCanto II system (BD Biosciences), and data were
analyzed using FlowJo software (v.10.0.8.). Cell sorting was per-
formed using a MoFlo Astrios High Speed Cell Sorter (Beckman
Coulter). The antibodies used are presented in Table S1.
Cell-Cycle Analysis
Cells were treated with BrdU for 6 h, stained for surface antigens,
and processed using an APC-BrdU Flow Kit (BD) according to the
manufacturer’s instructions.
Apoptosis Assays
Cells were detected by flow cytometry of cells stained according to
the manufacturer’s instructions with annexin V–APC and 7-AAD
(BioLegend).
Statistical Analysis
All data are presented as the mean ± SD. Statistical analyses were
performed using the Student’s t test. p < 0.05 was considered
significant.
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